| Home |  | News |
News
$1.5 Million to Fund Growth of Bacterial Management Solutions
Wednesday, November 4, 2009
Noble Biomaterials Inc., the world’s premier microbial management company has established a line of credit for 1.5 million dollars with Silicon Valley Bank of Santa Clara, CA. This facility by SVB follows on lending established with Noble in 2006.
Noble CEO Jeff Keane says that “this credit facility will allow for the continued growth of Noble’s mission to provide bacterial management solutions to high risk problems such as health care acquired infections and hard to heal wounds.”*
Tom Gordon, Senior Vice President of Silicon Valley Bank; reiterated “SVB feels strongly that Noble’s technology provides proprietary benefits to high value opportunities. The continuation of our 5 year banking relationship allows funding for these significant growth opportunities and is a logical extension of SVB’s life sciences strategy.”
Noble Biomaterials Inc is the premier anti microbial solutions provider to the athletic, military and health care markets. Based in Scranton, PA it is privately held by TL Ventures, DuPont Capital and Management.
Silicon Valley Bank is a leading provider of financial services to emerging, growing and established technology companies.
*EPA Regulated products containing X-STATIC® solely protect the finished product itself from microbial growth. Any public health claims related to X-STATIC® products are expressly limited to products regulated by the FDA.
Noble CEO Jeff Keane says that “this credit facility will allow for the continued growth of Noble’s mission to provide bacterial management solutions to high risk problems such as health care acquired infections and hard to heal wounds.”*
Tom Gordon, Senior Vice President of Silicon Valley Bank; reiterated “SVB feels strongly that Noble’s technology provides proprietary benefits to high value opportunities. The continuation of our 5 year banking relationship allows funding for these significant growth opportunities and is a logical extension of SVB’s life sciences strategy.”
Noble Biomaterials Inc is the premier anti microbial solutions provider to the athletic, military and health care markets. Based in Scranton, PA it is privately held by TL Ventures, DuPont Capital and Management.
Silicon Valley Bank is a leading provider of financial services to emerging, growing and established technology companies.
*EPA Regulated products containing X-STATIC® solely protect the finished product itself from microbial growth. Any public health claims related to X-STATIC® products are expressly limited to products regulated by the FDA.
   |
© 2010 Noble Biomaterials, Inc.